Clinical Trial Update: Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel [NA]

View source ↗

Summary

This clinical trial evaluates whether 68Ga-DOTATOC PET/CT-enterography can detect the primary lesion in small bowel neuroendocrine tumors, and the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor
• Small Bowel Neuroendocrine Tumor

Drugs mentioned

• 68Ga-DOTATOC (DOTATOC)

Snippet

Sponsor: European Institute of Oncology | Conditions: Small Bowel Neoplasia, Neuroendocrine (NE) Tumors | NA | Status: RECRUITING